Page 8 - MemoriaCIBER2019-ENG

8 CIBER Annual report 2019
Internal Organisation
The Centro de Investigación Biomédica en Red, M.P, CIBER, a public research consortium set up by the Instituto de Sa- lud Carlos III (ISCIII), furthers excellence research in Biomedicine and Health Sciences carried out in the National Health System and the Science and Technology System.
The CIBER’s scientific programme is based on the following thematic research areas:
• Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)
• Diabetes and Associated Metabolic Diseases (CIBERDEM)
• Physiopathology of Obesity and Nutrition (CIBEROBN)
• Liver and Digestive Diseases (CIBEREHD)
• Rare Diseases (CIBERER)
• Respiratory Diseases (CIBERES)
• Epidemiology and Public Health (CIBERESP)
• Mental Health (CIBERSAM)
• Frailty and Healthy Ageing (CIBERFES)
• Cardiovascular Diseases (CIBERCV)
• Cancer (CIBERONC)
At the present time, the Ciber has a staff of 879 persons and around 6.000 attached researchers integrated in over 420 research groups (7 outgoing groups and 8 incoming groups in 2019) working in separate locations, associated with 99 institutions in the consortium and belonging to administrations and public and private sector institutions of Spain’s different regional “Autonomous Communities”.
Its governing, management and administrative bodies are as follows:
Governing Board
and Permanent Commission
The Governing Board, presided over by the Director of the ISCIII, is made up of three representatives of the ISCIII and an institutional representative of each of the institutions in the consortium, appointed by their senior authorities. It meets every six months.